KALV Overview
Upcoming Projects (KALV)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (KALV)
-
Discussing sebetralstat and Kalvista's Phase 3 KONFIDENT trial data in treating hereditary angioedema (HAE)
Ticker: KALV
Executed On: Mar 07, 2024 at 11:00 AM EST -
Discussing HAE and sebetralstat as an on-demand therapy in the KONFIDENT trial from Kalvista Pharmaceuticals
Tickers: KALV, PHVS
Executed On: Jul 06, 2023 at 03:00 PM EDT -
An overview of the hereditary angioedema (HAE) treatment landscape with a focus on new therapies in development by Kalvista, Astria, and Pharvaris
Tickers: PHVS, KALV, ATXS
Executed On: Apr 05, 2023 at 04:00 PM EDT
Upcoming & Overdue Catalysts (KALV)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (KALV)
-
KalVista's (KALV) KVD900 in Hereditary Angioedema (HAE) Phase 2 data due 1Q 2021
Ticker: KALV
Occurred on: Feb 09, 2021 -
KalVista Pharmaceuticals (KALV) Reports KVD001 Phase 2 Clinical Trial Results in Patients with Diabetic Macular Edema
Ticker: KALV
Occurred on: Dec 09, 2019
Strategic Initiatives (KALV)
-
Don’t see a strategic initiative related to the company you care about? Create your own!